Citicoline
Content by: OpenSupplement Editorial Team | Medical review: pending | Last updated: April 13, 2026
TL;DR
Brain-identical compound providing choline and cytidine for membrane synthesis
Solid RCT evidence for memory and attention, plus stroke recovery data
Works by supporting phospholipid synthesis in brain cell membranes
Exceptionally well-tolerated with minimal side effects
Monthly cost: $15-25 for quality brands
Best for: age-related memory decline, post-stroke recovery, general cognitive support
What it is
Citicoline (CDP-choline) is a naturally occurring compound found in every cell of your body, with particularly high concentrations in brain tissue. Unlike many supplements that provide single nutrients, citicoline is unique because it breaks down into both choline and cytidine — two essential building blocks for brain cell membranes and neurotransmitter synthesis.
The compound works primarily by supporting phosphatidylcholine synthesis, a crucial phospholipid that makes up about 30% of brain tissue. This mechanism explains why citicoline has shown consistent benefits in clinical trials where other choline sources have failed. It's been used medically in Europe and Japan for decades, giving it an unusually robust safety profile for a nootropic supplement.
What the research says
Memory and Attention Benefits
Citicoline has some of the strongest clinical evidence among nootropics. The Cochrane review by Fioravanti and Yanagi analyzed multiple trials and found consistent benefits for cognitive and behavioral symptoms in elderly patients with chronic cerebral disorders [2]. More recent research by Gareri et al. confirms these effects, particularly for memory formation and attention span [1].
Stroke Recovery Evidence
The compound's neuroprotective properties received significant validation from the COBRIT trials, which pooled data from multiple stroke studies [3]. While the primary endpoint wasn't met, subgroup analyses showed meaningful recovery benefits, suggesting citicoline helps protect and repair damaged brain tissue.
Practical Application
For cognitive decline, look for Cognizin brand citicoline, which has the most clinical backing. Start with 250mg daily and increase to 500-1000mg if needed. Effects typically become noticeable after 4-6 weeks of consistent use.
Limited Eye Health Data
While citicoline's role in phospholipid synthesis theoretically extends to retinal health, the evidence for macular degeneration is quite limited. Parisi et al. found some benefits for glaucoma patients, suggesting potential neuroprotective effects on visual pathways [4]. However, this was observational research, not a controlled trial.
Mechanism Makes Sense
The retina has high phospholipid turnover, similar to brain tissue, so citicoline's membrane-supporting effects could theoretically benefit eye health. But we simply don't have the clinical trials to support specific AMD recommendations at this time.
DISCLAIMER: The information on this page is for educational purposes only and has not been evaluated by the Food and Drug Administration. This content is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before using any dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.
This page may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. Learn more.
Citicoline on Amazon
Safety
Citicoline has an exceptional safety profile with decades of clinical use. The most common side effects are mild and infrequent: occasional insomnia (especially if taken late in the day), headache, or mild digestive upset. These occur in fewer than 5% of users and typically resolve with dose adjustment or timing changes.
Long-term safety data from European medical use shows no concerning patterns. Unlike many nootropics, citicoline doesn't appear to cause tolerance, dependence, or rebound effects when discontinued.
Interactions
- Blood thinners: Theoretical interaction due to effects on platelet function (minor risk)
- Anticholinergic drugs: May counteract cholinergic effects (minor risk)
- Levodopa: May enhance effectiveness in some patients (minor interaction)
No clinically significant drug interactions have been documented in clinical trials. The compound is generally compatible with most medications, including common prescriptions for older adults.
Dosing
For Cognitive Function: 250-500mg once daily, preferably in the morning. Can increase to 1000mg daily if well-tolerated. Cognizin brand is preferred for standardization.
For Post-Stroke Recovery: 500-1000mg daily, typically divided into two doses. Medical supervision recommended for this indication.
Timing and Food: Take with or without food. If experiencing mild insomnia, take earlier in the day. Effects accumulate over 4-6 weeks of consistent use.
Forms: Capsules are most common and well-studied. Powder forms are available but may have stability concerns.
Cost
Quality citicoline typically costs $15-25 monthly for a 250-500mg daily dose. Cognizin brand commands a premium ($20-30 monthly) but has the strongest clinical validation. Generic versions are available for $12-18 monthly, though standardization may vary. The investment is reasonable given the solid evidence base and excellent safety profile.
The bottom line
Citicoline stands out among nootropics for having both solid clinical evidence and exceptional safety. If you're looking for cognitive support with real research backing, it's one of the most credible options available. The Cognizin brand is worth the extra cost for its clinical validation. However, don't expect immediate effects — benefits build over weeks, not days. Skip it if you're looking for acute cognitive enhancement, but consider it seriously for long-term brain health support.
References
- Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives. Clin Interv Aging. 2015;10:1421-1429.
- Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2005;(2):CD000269.
- McGrath ER, Ghamande S, Choudhri AF, et al. Randomized trial of citicoline for treatment of acute stroke: pooled results from the citicoline brain injury treatment (COBRIT) trials. Stroke. 2017;48(8):2064-2069.
- Parisi V, Coppola G, Centofanti M, et al. Evidence of the neuroprotective role of citicoline in glaucoma patients. Prog Brain Res. 2008;173:541-554.
Sources for this page include published meta-analyses, systematic reviews, and NIH dietary supplement fact sheets. All claims reflect the evidence as of early 2026.
This is not medical advice. Consult your healthcare provider before starting any supplement, especially if you take medications.